Abbott Laboratories is a global healthcare company headquartered in Abbott Park, Illinois, USA. Founded in 1888, Abbott develops and markets a broad range of diagnostics, medical devices, nutrition products, and branded generic pharmaceuticals.

About Abbott Laboratories

Abbott Laboratories is a global healthcare company based in Abbott Park, Illinois, founded in 1888. It specializes in the development, manufacture, and sale of healthcare products across diagnostics, medical devices, nutrition, and pharmaceuticals.

Abbott is widely recognized for innovations in diabetes care, diagnostic testing, and cardiovascular technologies. The company is listed on the New York Stock Exchange (NYSE) under the ticker ABT.

• Revenue: $41–43 billion
• Net Income: Approx. $6–7 billion
• Employees: ~115,000 in over 160 countries
• Market Cap: ~$180–200 billion (as of mid-2025)
• Ticker: ABT (NYSE)

Business segments:

1. Diagnostics: Core Laboratory, Molecular, and Rapid Diagnostics (including COVID-19 tests).
2. Medical Devices: Includes FreeStyle Libre (diabetes management), pacemakers, stents, and heart valves.
3. Nutrition: Infant formula (e.g., Similac), adult nutrition (e.g., Ensure, Glucerna).
4. Established Pharmaceuticals: Branded generics focused on emerging markets, especially Latin America and Asia.

Abbott operates in 160+ countries and earns more than 70% of its revenue from outside the United States, with strong manufacturing and distribution networks worldwide.

• Mission: To help people live their best and healthiest lives.
• Focus areas include health innovation, digital health expansion, sustainability, and accessible care.
• Abbott has received global recognition for ESG practices, innovation in diagnostics, and commitment to emerging markets.

Vision dan Mission Abbott Laboratories 

Vision Statement

“A world where everyone has the opportunity for a healthier life.”

Abbott envisions a future where healthcare is accessible, innovative, and empowering for all people. This vision emphasizes inclusivity, global outreach, and continuous advancement in health technologies.

Mission Statement

“To help people live their best lives through the power of health.”

Abbott’s mission focuses on enhancing lives through science and innovation. It reflects the company’s dedication to developing reliable, life-changing healthcare solutions that empower individuals and improve well-being at every stage of life.

Key Pillars of Abbott’s Mission

1. Innovation in Science – Pioneering new technologies in diagnostics, medical devices, and nutrition.
2. Accessibility and Affordability – Expanding healthcare access in both developed and emerging markets.
3. Global Health Equity – Working with communities, governments, and partners to address health challenges around the world.
4. Sustainability and Ethics – Maintaining strong ethical standards and reducing environmental impact across operations.

Abbott aligns its strategic goals with the United Nations Sustainable Development Goals (SDGs), especially in the areas of good health and well-being.

Products of Abbott Laboratories

Abbott Laboratories offers a diverse portfolio of medical, nutritional, pharmaceutical, and diagnostic products. The company serves hospitals, clinics, laboratories, and consumers across over 160 countries.

1. Diagnostics

Abbott is a leader in diagnostic testing technologies, helping detect diseases faster and more accurately.

• Core Laboratory Systems – Clinical chemistry, immunoassay, hematology platforms.
• Molecular Diagnostics – Real-time PCR and viral load testing.
• Rapid Diagnostics – COVID-19 test kits, BinaxNOW™, flu tests, strep tests, and cardiac marker testing.
• Point-of-Care Solutions – i-STAT system for portable blood analysis.

2. Medical Devices

Abbott provides innovative devices that support chronic disease management and life-saving interventions.

• Diabetes Care – FreeStyle Libre, a continuous glucose monitoring system.
• Cardiovascular Devices – Heart stents, valves, pacemakers, and structural heart devices like MitraClip.
• Neuromodulation – Devices for chronic pain and movement disorders.
• Electrophysiology – Tools for diagnosing and treating cardiac arrhythmias.

3. Nutrition Products

Abbott is one of the world’s top producers of scientifically formulated nutrition products.

• Infant & Pediatric Nutrition – Similac, PediaSure.
• Adult Nutrition – Ensure, Glucerna (diabetes-specific nutrition), Nepro (renal care).

4. Established Pharmaceuticals

Focused mainly in emerging markets, Abbott provides branded generic medicines for infectious diseases, pain relief, gastrointestinal health, and women’s health.

Key Figures at Abbott Laboratories

1. Robert B. Ford – Chairman & Chief Executive Officer (CEO)

• Appointed CEO in March 2020 and Chairman in December 2020.
• Joined Abbott in 1996 and has held leadership roles in diagnostics and medical devices.
• Under his leadership, Abbott expanded its diagnostics portfolio and drove global growth in digital health and FreeStyle Libre.

2. Robert E. Funck, Jr. – Executive Vice President, Finance & Chief Financial Officer (CFO)

• Oversees Abbott’s global finance operations including investor relations and strategic planning.
• Joined Abbott in 1987, with extensive experience in corporate accounting and financial strategy.

3. Lisa Earnhardt – Executive Vice President, Medical Devices

• Leads the global medical devices division, including cardiovascular and neuromodulation businesses.
• Known for advancing innovation in life-saving technologies and women in STEM leadership.

4. Andrea Wainer – Executive Vice President, Rapid & Molecular Diagnostics

• Heads the diagnostics division responsible for COVID-19 testing, molecular systems, and point-of-care solutions.
• Plays a key role in driving public health access and lab innovations.

5. Daniel Salvadori – Executive Vice President, Nutrition

• Leads Abbott’s global nutrition business (e.g., Similac, Ensure, PediaSure).
• Focuses on scientific research, market expansion, and consumer health needs.

Stock Price Abbott Laboratories

Abbott Laboratories (ABT) has experienced moderate volatility with a consistent long-term upward trend, supported by its strong fundamentals, diversified product portfolio, and resilience during global health events.

• 2018–2019: ABT shares traded steadily between $60–$85, driven by growth in diagnostics and medical devices.
• 2020: The stock surged to $110+ during the COVID-19 pandemic due to the success of its rapid testing kits and diagnostics segment.
• 2021: ABT peaked near $135 amid continued strength in FreeStyle Libre sales and COVID-related demand.
• 2022–2023: Market corrections, inflation concerns, and post-pandemic normalization caused the stock to retrace to the $95–$105 range.
• 2024–2025 (YTD): ABT has been gradually recovering, trading around $110–$118 (as of mid-2025), driven by steady earnings, strong demand for diabetes devices, and growth in emerging markets.

Key Price Drivers

• Diagnostics performance, especially in infectious disease testing.
• Growth in medical devices, particularly FreeStyle Libre and cardiovascular solutions.
• Macroeconomic conditions (interest rates, inflation).
• Pharmaceutical sales in emerging markets.
• Investor sentiment toward defensive healthcare stocks.

History and Evolution of Abbott Laboratories

Founding and Early Years (1888–1920s)

• Abbott Laboratories was founded in 1888 by Dr. Wallace C. Abbott, a Chicago-based physician who formulated drugs from natural alkaloids.
• The company officially incorporated in 1900 and began producing dosimetric tablets to improve medicine dosing accuracy.
• Early on, Abbott expanded into international markets and built a reputation for reliable pharmaceutical products.

Mid-20th Century Growth (1930s–1970s)

• Abbott grew rapidly by producing antibiotics, vitamins, and anesthetics.
• It entered the nutrition field with the introduction of Similac® infant formula in the 1920s and Ensure® in the 1970s.
• The company went public on the Chicago Stock Exchange in 1929 and joined the New York Stock Exchange in 1939.

Innovation & Global Expansion (1980s–2000s)

• Abbott pioneered in diagnostic testing systems, becoming a leader in hospital lab equipment.
• It acquired Ross Laboratories (nutrition) and Knoll Pharmaceuticals (branded generics).
• By the early 2000s, Abbott had operations in over 130 countries, with growing segments in medical devices and diagnostics.

Strategic Transformation (2010s–2020s)

• In 2013, Abbott spun off its research-based pharmaceutical division as a new company: AbbVie (NYSE: ABBV), which retained blockbuster drugs like Humira.
• Post-spin-off, Abbott focused on four core segments: Diagnostics, Medical Devices, Nutrition, and Established Pharmaceuticals.
• The launch of FreeStyle Libre in 2014 revolutionized diabetes care, becoming a top global product.

Modern Era and Global Health Leadership

• Abbott played a major role in COVID-19 testing with products like BinaxNOW™ and molecular diagnostics tools.
• As of 2025, Abbott operates in over 160 countries, with a strong focus on accessible healthcare, digital health, and sustainability.

How to Buy Abbott Laboratories Stocks

Interested in buying shares of this tech company? You can buy Abbott Laboratories (ABT) shares with simple steps:

1. Install Nanovest app on the App Store or Play Store.
2. Register according to the instructions.
3. Verify your identity for security and convenience when buying stocks through the KYC feature which you can do in just 1 minute.
4. Top Up your balance to your Nanovest account.
5. Go to the stock menu, search and select Abbott Laboratories (ABT).
6. Click the Buy button and confirm the purchase with your desired amount. You can start with only IDR 5,000.

Before investing in the stocks you want, do some research and analysis first. You can do this by checking company profile, industry conditions, company financial reports, and analyzing previous stock price movements. This analysis is important so that you can develop an accurate investment strategy and minimize losses.

Is It Safe to Buy Abbott Laboratories Stock on Nanovest?

Of course. Nanovest is supported by a number of professional partners who have a good reputation in providing their services. One of them is supported by S-Quantum Engine technology by Sinarmas Financial Services.

For global and US stocks, Nanovest partners with brokers registered with the United Stated Financial Industry Regulatory Authority (FINRA) – which insures brokerage accounts held by Nanovest users up to U$S 500k by the United States Securities Investor Protection Corporation (SIPC).

For crypto assets, Nanovest is registered with the Commodity Futures Trading Supervisory Agency (Bappebti). The Nanovest platform itself has also been insured through a partnership with Sinarmas Insurance.

Disclaimer

All content on this website is for informational purposes and doesn’t constitute a recommendation to buy/sell any stock or digital asset. Investors should understand the nature of stocks and digital assets, including return and risk requirements of the assets. We encourage investors to fully understand the assets and risks before making any investment. Always do your own research.

See More Stocks

• Netflix, Inc. (NFLX) Stocks
• Meta Platforms, Inc. (META) Stocks
• Alphabet Inc. Class C (GOOG) Stocks
• Spotify Technology SA (SPOT) Stocks
• Amazon.com, Inc. (AMZN) Stocks
• Intel Corporation (INTC) Stocks
• Apple Inc. (AAPL) Stocks
• Microsoft Corporation (MSFT) Stocks
• Tesla, Inc. (TSLA) Stocks
• Alibaba Group (BABA) Stocks
• Visa Inc. (V) Stocks
• Citigroup Inc. (C) Stocks
• JPMorgan Chase & Co (JPM) Stocks
• HSBC Holdings plc (HSBC) Stocks
• Chevron Corporation (CVX) Stocks
• General Motors Co (GM) Stocks